7Nakanishi N,Suzuki K,Tatara K.Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanesemen[J].Diabetes Care,2004,27(6):1427-1432.
5Ryan MJ, Didion SP, Mathur S, et al. PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension, 2004, 43:661-666.
6Raji A, Seely EW, Bekins SA, et al. Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients. Diabetes Care, 2003, 26:172-178.
7He J, Klag MJ, Caballero B, et al. Plasma insulin level and incidence of hypertension in African Americans and whites. Arch Intern Med, 1999,159:498-503.
8Zavaroni I, Bonini L, Gasparini P, et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism,1999,48: 989-994.
9Salonen JT, Lakka TA, Lakka HM, et al. Hyperinsulinemia is associated with the incidence of hypertension and dislipidemia in middle-aged men. Diabetes, 1998, 47: 270-275.
10Tsuruta M, Hashmoto R, Adachi H, et al. Hyperinsulinemia as a predictor of hypertension: an 11-year follow-up study in Japan. J Hypertens, 1996, 14:483-488.
